Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

What symbol and exchange does Lipocine shares trade?

Lipocine trades on the NASDAQ stock market under the symbol LPCN.

What is Lipocine stock price doing today?

As of November 6, 2026, LPCN stock price climbed to $1.57 with 492,194 million shares trading.

What is Lipocine's Beta?

LPCN has a beta of -1.77, meaning it tends to be less sensitive to market movements. LPCN has a correlation of 0.02 to the broad based SPY ETF.

How much is Lipocine worth?

LPCN has a market cap of $12.94 million. This is considered a Sub-Micro Cap stock.

How much money does Lipocine make?

Last quarter Lipocine reported $2 million in Revenue and -$.08 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.28.

What is the highest and lowest price Lipocine traded in the last 3 year period?

In the last 3 years, LPCN traded as high as $12.37 and as low as $1.36.

What are the top ETFs holding Lipocine?

The top ETF exchange traded funds that LPCN belongs to (by Net Assets): VTI, VXF, DFSU, DCOR, DFMC.

Is Lipocine (LPCN) a good investment?

LPCN has underperformed the market in the last year with a return of -40.5%, while the SPY ETF gained +10.8%. In the last 3 month period, LPCN fell short of the market, returning -26.3%, while SPY returned -4.1%. However, in the most recent 2 weeks LPCN has outperformed the stock market by returning +9.0%, while SPY returned -3.2%.

What are the support and resistance levels for Lipocine (LPCN)?

LPCN support price is $1.45 and resistance is $1.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LPCN shares will trade within this expected range on the day.